Cargando…
Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1
Oncolytic viruses are potent anticancer agents that replicate within and kill cancer cells rather than normal cells, and their selectivity is largely determined by oncogenic mutations. M1, a novel oncolytic virus strain, has been shown to target cancer cells, but the relationship between its cancer...
Autores principales: | Cai, Jing, Lin, Kaiying, Cai, Wei, Lin, Yuan, Liu, Xincheng, Guo, Li, Zhang, Jifu, Xu, Wencang, Lin, Ziqing, Wong, Chun Wa, Sander, Max, Hu, Jun, Yan, Guangmei, Zhu, Wenbo, Liang, Jiankai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718955/ https://www.ncbi.nlm.nih.gov/pubmed/33037696 http://dx.doi.org/10.1002/1878-0261.12820 |
Ejemplares similares
-
Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
por: Cai, Jing, et al.
Publicado: (2020) -
DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
por: Xiao, Xiao, et al.
Publicado: (2018) -
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors
por: Song, Deli, et al.
Publicado: (2022) -
Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade
por: Liu, Yang, et al.
Publicado: (2020) -
A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1
por: Li, Kai, et al.
Publicado: (2016)